论文部分内容阅读
冬虫夏草是名贵中药材,具有滋补强壮作用。由于野生资源少,价格昂贵,造成货源奇缺。中国医学科学院药物研究所1972年开始对冬虫夏草进行了研究。1982年与江西国药厂协作进行扩大试制。经化学、药理研究,证明人工发酵虫草菌与天然虫草一致。经500余例临床,对降血脂、气管炎、性功能低下等治疗疗效较好,并于1985年3月27～30日在南昌召开评审会及成果鉴定会,参加会议的来自8个省市、46个单位、106位代表,与会代表一致
Cordyceps sinensis is a valuable Chinese herbal medicine that has nourishing and strengthening effects. Due to the scarcity of wild resources and the high price, the supply of goods is scarce. The Institute of Materia Medica, Chinese Academy of Medical Sciences began research on Cordyceps sinensis in 1972. In 1982, it cooperated with Jiangxi National Pharmaceutical Factory to expand trial production. Chemical and pharmacological studies have proved that artificial fermented Cordyceps is consistent with natural Cordyceps. After more than 500 clinical trials, the curative effect on hypolipidemic, bronchitis, and hypogonadism was good, and a review meeting and results appraisal meeting was held in Nanchang from March 27 to March 1985. The participants from 8 provinces and cities , 46 units, 106 delegates, in accordance with the delegates